Acute back pain (ED red-flag workup)
Encounter flow
12/12 authoredCanonical 12-phase frame with authored status for this dossier.
Frame
Pain onset, location, quality; SNNOOP10 red-flag screen anchored (ACP 2017 PMID 28192789; Stochkendahl PMID 33558739)
pain characterized + red-flag screen run
Patient inputs (32)
Age >50 with new back pain raises red-flag prior (malignancy, fracture, AAA, dissection) (ACP 2017 PMID 28192789)
Pregnancy raises differential (preeclampsia, abruption, MSK from biomechanics); reproductive-age females need β-hCG before imaging
Hypotension flags AAA leak / dissection / urosepsis (Sakalihasan 2018; SSC 2026)
Tachycardia in volume loss / dissection / sepsis
Fever raises infection prior (SEA / osteomyelitis / pyelonephritis) (Berbari IDSA 2015 PMID 28118470)
Known malignancy (breast, lung, prostate, renal, multiple myeloma, lymphoma) — new back pain warrants STAT MRI for metastatic cord compression
IVDU / immunosuppression / diabetes / chronic steroid / dialysis / recent spinal procedure → SEA prior (Bond 2016 PMID 28121397)
Osteoporosis or chronic glucocorticoid use → fragility vertebral fracture prior (Genant PMID 20308793)
High-energy trauma → unstable fracture risk; low-energy in osteoporosis → compression fracture
Smoking + HTN + male + >65 + family history → AAA / dissection (Sakalihasan 2018 PMID 23335416)
Anticoagulation raises spontaneous epidural hematoma prior (rare but mimics SEA / cauda equina)
Pregnancy → preeclampsia / HELLP; postpartum → cortical vein thrombosis with referred back pain
Sciatica (L4-S1 dermatome) = radiculopathy; anterior thigh = L2-L4; chest = thoracic dissection; groin = AAA or urolithiasis (ACP 2017)
Saddle anesthesia (S2-S4) is the most specific feature of cauda equina syndrome — STAT MRI threshold (Kuris 2015 PMID 26416327)
New urinary retention / fecal incontinence / overflow urinary incontinence — late but specific cauda equina feature (Kuris 2015)
Bilateral lower extremity weakness or paresthesia raises cauda equina prior dramatically (Kuris 2015)
Persistent fever + back pain + IVDU or immunocompromise → spinal epidural abscess (Bond 2016 PMID 28121397; Berbari IDSA 2015 PMID 28118470)
Night pain or pain at rest unrelieved by position raises malignancy / infection prior (ACP 2017)
Progressive motor weakness / progressive sensory loss / progressive bowel-bladder symptoms is RED-FLAG (Kuris 2015; ACP 2017)
Sudden maximal-intensity onset = AAA / dissection / acute fracture; gradual = inflammatory / mechanical (Sakalihasan 2018; ACP 2017)
Cervical / thoracic / lumbar; midline vs paraspinal vs flank — anchors differential (mechanical vs visceral vs aortic) (ACP 2017)
Tearing = dissection / AAA; constant + worse at night = malignancy / infection; mechanical worse with movement / better with rest = MSK (ACP 2017; Berbari IDSA PMID 28118470)
Leukocytosis in SEA / osteomyelitis / pyelonephritis; anemia in malignancy or bleeding (Bond 2016)
ESR + CRP screening for SEA / osteomyelitis — CRP >50 or ESR >50 raises suspicion; high NPV when both normal (Berbari IDSA 2015 PMID 28118470; Bond 2016)
UA for hematuria (urolithiasis) / pyuria + nitrites (pyelonephritis); β-hCG if reproductive-age female
eGFR for contrast decisions (CTA / MRI gad) and dosing
Plain films are LOW-yield for soft tissue / SEA / cauda equina but useful for compression fracture screen (ACP 2017)
GOLD STANDARD for cauda equina / SEA / osteomyelitis / metastatic compression — STAT, gadolinium-enhanced (Kuris 2015; Bond 2016; Berbari IDSA 2015)
CTA chest for thoracic dissection (AHA 2022); CTA abdomen for AAA (Sakalihasan PMID 23335416)
CT KUB for urolithiasis (flank pain + hematuria)
>20 mmHg differential between arms suggests thoracic aortic dissection (AHA 2022)
Blood cultures × 2 BEFORE antibiotics for SEA / osteomyelitis / urosepsis (Berbari IDSA 2015)
* = hard-required. Engine cannot meaningfully run until these are filled.
Severity triggers (12)
- informationallife_threateningcauda_equina_syndromeSaddle anesthesia (S2-S4) + new bowel/bladder dysfunction + bilateral leg weakness OR PVR >200 mL — STAT MRI lumbar gadolinium + neurosurgery consult (Kuris 2015 PMID 26416327)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningspinal_epidural_abscessFever + IVDU OR immunocompromise OR recent spinal procedure + new back pain + elevated CRP/ESR — STAT MRI gad + neurosurgery (Bond 2016 PMID 28121397; Berbari IDSA PMID 28118470)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningmetastatic_cord_compressionKnown cancer (breast, lung, prostate, renal, multiple myeloma, lymphoma) + new back pain + neuro deficit or night pain — STAT MRI + dexamethasone + oncology + RT/neurosurgeryTrigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningaaa_leak_with_back_painHypotension + flank/midline back or abdominal pain + age >65 + male smoker + vascular risk + pulsatile mass (poor sensitivity) — STAT CTA aorta (Sakalihasan PMID 23335416)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningthoracic_aortic_dissection_backTearing thoracic back / interscapular pain + BP differential between arms >20 mmHg + HTN/Marfan/bicuspid AV/prior dissection — STAT CTA chest (AHA 2022)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningspontaneous_epidural_hematomaAnticoagulation + abrupt severe back pain + neuro deficit — STAT MRI gad + reversal + neurosurgeryTrigger could not be auto-evaluated — needs clinician judgement.
- informationalseverevertebral_osteomyelitisInsidious progressive back pain + fever + elevated ESR/CRP + IVDU/dialysis/diabetes/immunocompromise — MRI gad + biopsy + IDSA antibiotics (Berbari IDSA 2015 PMID 28118470)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseverepyelonephritis_urosepsisFlank pain + dysuria + fever + pyuria/nitrites on UA + sepsis features (qSOFA ≥2 OR lactate >2) — IDSA UTI + SSC 2026 sepsis bundleTrigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereprogressive_neuro_deficitProgressive motor weakness OR progressive sensory loss OR progressive bowel/bladder symptoms over hours to days — STAT MRI + neurosurgery consult (Kuris 2015; Bond 2016)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatevertebral_compression_fractureOsteoporosis OR chronic glucocorticoid use + minor trauma + acute focal back pain + thoracolumbar tenderness — XR/MRI; Genant grading I-III (PMID 20308793)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderaterenal_colic_urolithiasisColicky flank pain radiating to groin + hematuria + cannot find comfortable position + age 30-50 — CT KUB non-contrast (uro.urolithiasis.v1 routing)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmildmechanical_back_pain_no_red_flagAcute low back pain without any SNNOOP10 red flag + benign exam + functional — discharge with conservative care + PCP follow-up 1-2 weeks (ACP 2017 PMID 28192789; USPSTF PMID 29457591; Stochkendahl PMID 33558739)Trigger could not be auto-evaluated — needs clinician judgement.
Workflow calculators
Run this disease's risk and dosing calculators inline.
Recommended regimen
ed playbook — drug actions (7)
- 1. acetaminophenrxcui 161650-1000 mg PO/IV • PO or IV • q4-6h max 4 g/daytrigger: Mild-moderate back pain without red flagsACP 2017 PMID 28192789 — acetaminophen first-line for acute back pain
- 2. ibuprofen OR naproxenrxcui 5640Ibuprofen 400-600 mg PO q6h OR naproxen 500 mg PO BID • PO • short course (≤7-14 d)trigger: Moderate pain inadequate with acetaminophen alone; no renal/GI/bleeding contraindicationACP 2017 — NSAIDs are first-line pharmacotherapy for acute low back pain
- 3. cyclobenzaprinerxcui 219495-10 mg PO TID • PO • q8h × 3-7 dtrigger: Muscle spasm componentACP 2017 — skeletal muscle relaxants for short-term acute use only; sedation in elderly per AGS Beers
- 4. morphine OR oxycodoneMorphine 4-8 mg IV q15-30 min PRN OR oxycodone 5-10 mg PO q6h • IV or PO • short course onlytrigger: Severe acute pain refractory to non-opioid OR functional impairment (NRS ≥7) + appropriate risk-benefitACP 2017 + USPSTF 2018 — opioids only for severe acute pain refractory to non-opioid; lowest effective dose × shortest duration
- 5. vancomycin + ceftriaxone OR cefepimeVanc 15-20 mg/kg IV (loading) + ceftriaxone 2 g IV daily OR cefepime 2 g IV q8h • IV • AFTER blood culturestrigger: Confirmed or strongly suspected spinal epidural abscess or vertebral osteomyelitis on MRIIDSA 2015 PMID 28118470 — empiric vanc + 3rd/4th gen cephalosporin pending culture; tailor to organism; 6-8 weeks IV typically
- 6. dexamethasonerxcui 326410 mg IV loading then 4 mg IV q6h • IV • until MRI + RT plantrigger: Suspected metastatic cord compression (known cancer + new back pain + neuro deficit)Reduces cord edema bridging to definitive RT/surgery; route to oncology + radiation oncology + spine surgery
- 7. esmolol or labetalolEsmolol 500 mcg/kg bolus then 50 mcg/kg/min; labetalol 10-20 mg IV • IV • titrate HR <60 + SBP <120trigger: Suspected thoracic aortic dissection (tearing thoracic back pain + BP differential)AHA 2022 Acute Aortic Disease — impulse control FIRST before vasodilator; route to cardio.aortic-dissection.core.v1
Auto-drafted A&P note
edSubjective
- Possible entry pathways: Acute back pain (low / thoracic / cervical) — drives red-flag screen first (ACP Qaseem 2017 PMID 28192789); Back pain with sciatica or radiculopathy — assess motor/sensory deficit per dermatome (ACP 2017); Back pain + motor weakness or saddle anesthesia or bowel/bladder dysfunction → SUSPECT CAUDA EQUINA — STAT MRI (Kuris 2015 PMID 26416327).
Objective
- No vitals, labs, or imaging entered for this encounter.
Assessment
**Acute back pain (ED red-flag workup)** (symptom.back_pain.ed.v1). Phenotype framing: Mechanical/MSK (>85%) / sciatica + radiculopathy (~10-15%) / cauda equina (~1/1000-5000 in ED back pain) / spinal epidural abscess (~0.2-1.2/10000) / vertebral osteomyelitis / metastatic compression (~5% of cancer patients) / vertebral fracture (osteoporotic) / AAA leak (~0.1% of ED back pain) / aortic dissection (~0.3%) / pyelonephritis / renal colic / spinal stenosis (chronic — neurogenic claudication) / ankylosing spondylitis / fibromyalgia (chronic; exclusion) (ACP 2017 PMID 28192789; Stochkendahl 2018 PMID 33558739) Scope: Pain onset, location, quality; SNNOOP10 red-flag screen anchored (ACP 2017 PMID 28192789; Stochkendahl PMID 33558739) No severity triggers fired against current inputs.
Plan
No regimen axis selected (engine has no regimen_axes or could not match). Setting playbook (ed) — Red-flag rule-out — do NOT miss cauda equina syndrome, spinal epidural abscess, vertebral osteomyelitis, metastatic cord compression, vertebral fracture, AAA leak, thoracic dissection, urosepsis. Mechanical/MSK back pain (>85%) is a diagnosis of exclusion after SNNOOP10 screen + targeted imaging if any flag positive. ACP 2017 + USPSTF 2018 + Stochkendahl 2018 guideline implementation. 1. acetaminophen 650-1000 mg PO/IV PO or IV q4-6h max 4 g/day — Mild-moderate back pain without red flags (ACP 2017 PMID 28192789 — acetaminophen first-line for acute back pain) 2. ibuprofen OR naproxen Ibuprofen 400-600 mg PO q6h OR naproxen 500 mg PO BID PO short course (≤7-14 d) — Moderate pain inadequate with acetaminophen alone; no renal/GI/bleeding contraindication (ACP 2017 — NSAIDs are first-line pharmacotherapy for acute low back pain) 3. cyclobenzaprine 5-10 mg PO TID PO q8h × 3-7 d — Muscle spasm component (ACP 2017 — skeletal muscle relaxants for short-term acute use only; sedation in elderly per AGS Beers) 4. morphine OR oxycodone Morphine 4-8 mg IV q15-30 min PRN OR oxycodone 5-10 mg PO q6h IV or PO short course only — Severe acute pain refractory to non-opioid OR functional impairment (NRS ≥7) + appropriate risk-benefit (ACP 2017 + USPSTF 2018 — opioids only for severe acute pain refractory to non-opioid; lowest effective dose × shortest duration) 5. vancomycin + ceftriaxone OR cefepime Vanc 15-20 mg/kg IV (loading) + ceftriaxone 2 g IV daily OR cefepime 2 g IV q8h IV AFTER blood cultures — Confirmed or strongly suspected spinal epidural abscess or vertebral osteomyelitis on MRI (IDSA 2015 PMID 28118470 — empiric vanc + 3rd/4th gen cephalosporin pending culture; tailor to organism; 6-8 weeks IV typically) 6. dexamethasone 10 mg IV loading then 4 mg IV q6h IV until MRI + RT plan — Suspected metastatic cord compression (known cancer + new back pain + neuro deficit) (Reduces cord edema bridging to definitive RT/surgery; route to oncology + radiation oncology + spine surgery) 7. esmolol or labetalol Esmolol 500 mcg/kg bolus then 50 mcg/kg/min; labetalol 10-20 mg IV IV titrate HR <60 + SBP <120 — Suspected thoracic aortic dissection (tearing thoracic back pain + BP differential) (AHA 2022 Acute Aortic Disease — impulse control FIRST before vasodilator; route to cardio.aortic-dissection.core.v1) Non-pharmacologic actions: - Two IVs if hemodynamically unstable or imaging planned - Foley catheter for post-void residual + monitoring if cauda equina suspected - STAT MRI lumbar spine (or relevant level) WITH gadolinium if cauda equina / SEA / osteomyelitis / metastatic compression suspected — do NOT delay for trial of conservative therapy - Neurosurgery / spine surgery consult STAT for cauda equina (decompression goal <24-48 h) OR SEA with neuro deficit - Oncology + radiation oncology consult for confirmed metastatic cord compression (steroid bridge → RT or decompressive surgery per SCORS criteria) - Vascular surgery consult for confirmed AAA leak or thoracic dissection - Urology consult for complicated urolithiasis (obstruction + infection) - Avoid bed rest >2 days for mechanical back pain (ACP 2017) - PT referral for subacute / chronic mechanical back pain (USPSTF 2018; Stochkendahl 2018)
Monitoring
Setting (ed) monitoring: - Vital signs q30 min × 2 h then per disposition - Continuous SpO2 and telemetry if dissection or AAA suspicion - Neuro exam q4-6h on observation — motor, sensory (saddle), reflexes, rectal tone, PVR - Pain reassessment 30 min post analgesia - Repeat ESR + CRP trending for confirmed SEA/osteomyelitis (Berbari IDSA 2015) Follow-up plan: Mechanical/MSK discharged: PCP within 1-2 weeks; conservative care (early mobilization, heat, NSAID, PT); avoid bed rest >2 days; return precautions (worsening pain, new neuro deficit, fever, bowel/bladder, weight loss); ACP 2017 + USPSTF 2018 endorse exercise / PT / cognitive-behavioral / spinal manipulation for subacute - Close-out criterion: discharge bundle prescribed + follow-up scheduled Monitoring phase: Serial neuro exam q4-6h on observation; pain reassessment; recheck red flags if symptom evolution; serial ESR/CRP trending for confirmed SEA/osteo (Berbari IDSA 2015)
Disposition
Current setting: ed — Red-flag rule-out — do NOT miss cauda equina syndrome, spinal epidural abscess, vertebral osteomyelitis, metastatic cord compression, vertebral fracture, AAA leak, thoracic dissection, urosepsis. Mechanical/MSK back pain (>85%) is a diagnosis of exclusion after SNNOOP10 screen + targeted imaging if any flag positive. ACP 2017 + USPSTF 2018 + Stochkendahl 2018 guideline implementation. Disposition criteria: - Discharge: mechanical/MSK back pain WITHOUT red flags + functional + reliable PCP follow-up 1-2 weeks + return precautions documented (ACP 2017; USPSTF 2018) - Observation: equivocal MRI / awaiting ESR-CRP trend / cauda equina rule-out pending after PVR + neuro exam - Admit: confirmed SEA, osteomyelitis, metastatic compression, complicated pyelonephritis, vertebral fracture with neuro deficit, severe pain with functional impairment, social inability to manage at home - OR direct: cauda equina syndrome (decompression goal <24-48 h); SEA with progressive neuro deficit; unstable vertebral fracture with neuro deficit; AAA leak; aortic dissection Stanford A - ICU: hemodynamic instability; AAA / dissection awaiting OR; septic shock from urosepsis Escalation triggers (move to higher acuity): - New or progressive saddle anesthesia + bowel/bladder + bilateral leg weakness → STAT MRI + neurosurgery within 24-48 h (Kuris 2015 PMID 26416327) - Fever + IVDU/immunocompromise + new back pain + elevated CRP/ESR → STAT MRI gad + IDSA empiric antibiotics + neurosurgery (Bond 2016 PMID 28121397) - Known cancer + new back pain + neuro deficit or night pain → STAT MRI + dexamethasone + oncology + RT/neurosurgery - Hypotension + flank/midline back pain + age >65 → STAT CTA aorta → vasc.aaa.v1 + vascular surgery - Tearing thoracic back pain + BP differential → STAT CTA chest → cardio.aortic-dissection.core.v1 + vascular/CT surgery - Pyelonephritis + sepsis criteria → id.sepsis.core.v1 + admission - Pediatric back pain — separate workup (less common; higher relative malignancy/infection prior); not in this engine scope
Earlier-Return Triggers
Return-precaution thresholds (watch for): - [LIFE_THREATENING] Saddle anesthesia (S2-S4) + new bowel/bladder dysfunction + bilateral leg weakness OR PVR >200 mL — STAT MRI lumbar gadolinium + neurosurgery consult (Kuris 2015 PMID 26416327) - [LIFE_THREATENING] Fever + IVDU OR immunocompromise OR recent spinal procedure + new back pain + elevated CRP/ESR — STAT MRI gad + neurosurgery (Bond 2016 PMID 28121397; Berbari IDSA PMID 28118470) - [LIFE_THREATENING] Known cancer (breast, lung, prostate, renal, multiple myeloma, lymphoma) + new back pain + neuro deficit or night pain — STAT MRI + dexamethasone + oncology + RT/neurosurgery
Citations
- 2017 ACP Qaseem low back pain guideline + 2018 USPSTF + 2018 Stochkendahl ACP implementation + 2015 IDSA Berbari osteomyelitis + 2016 Bond SEA + 2015 Kuris cauda equina + Genant compression fracture grading + AHA 2022 Acute Aortic Disease + 2018 Sakalihasan AAA [PMID:28192789](https://pubmed.ncbi.nlm.nih.gov/28192789/) - Cited evidence (PMID 10584107) [PMID:10584107](https://pubmed.ncbi.nlm.nih.gov/10584107/) Last reconciled with current guidelines: 2026-05-30.
- 2017 ACP Qaseem low back pain guideline + 2018 USPSTF + 2018 Stochkendahl ACP implementation + 2015 IDSA Berbari osteomyelitis + 2016 Bond SEA + 2015 Kuris cauda equina + Genant compression fracture grading + AHA 2022 Acute Aortic Disease + 2018 Sakalihasan AAA — PMID:28192789
- Cited evidence (PMID 10584107) — PMID:10584107